What is the Share Price of Jagsonpal Pharmaceuticals Ltd?

Jagsonpal Pharmaceuticals Ltd share price is ₹218.48 As on 27 March, 2025|09:32

Home
>
Stocks
>
Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd Share Price

Q: What is the Market Cap of Jagsonpal Pharmaceuticals Ltd?

The Market Cap of Jagsonpal Pharmaceuticals Ltd is ₹1,407 As on 27 March, 2025|09:32

Q: What is PE Ratio of Jagsonpal Pharmaceuticals Ltd?

The P/E ratio of Jagsonpal Pharmaceuticals Ltd is 38.6 As on 27 March, 2025|09:32

Q: What is PB Ratio of Jagsonpal Pharmaceuticals Ltd?

The PB ratio of Jagsonpal Pharmaceuticals Ltd is 7.36 As on 27 March, 2025|09:32

₹ 218.48 +7.43 (3.52%)
Updated on 27-03-2025 9:32 AM

Stock Rating

Pros 4

Cons 2

Jagsonpal Pharmaceuticals Ltd Price Performance

Day's Low
₹210.61

Day's High
₹219.9

₹ 218.48

52-w low
₹109.44

52-w high
₹328.04

218.48

Day's open
₹214.4
Previous close
₹211.050003
VWAP
₹215.73
Lower price band
₹168.84
Upper price band
₹253.26

Today's Market Action

The last traded share price of Jagsonpal Pharmaceuticals Ltd was 218.48 up by 3.52% on the NSE. Its last traded stock price on BSE was 218.25 up by 3.61%. The total volume of shares on NSE and BSE combined was 27,584 shares. Its total combined turnover was Rs 0.60 crores.

Jagsonpal Pharmaceuticals Ltd Medium and Long Term Market Action

Jagsonpal Pharmaceuticals Ltd hit a 52-week high of 328.04 on 29-11-2024 and a 52-week low of 109.44 on 27-03-2024. The stock price of Jagsonpal Pharmaceuticals Ltd is down by -0% over the last one month. Don't forget to check the full stock price history in the table below.

Jagsonpal Pharmaceuticals Ltd Fundamentals

Market Cap (Cr): 1407
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Jagsonpal Pharmaceuticals Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Jagsonpal Pharmaceuticals Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Jagsonpal Pharmaceuticals Ltd

Data not available.

Jagsonpal Pharmaceuticals Ltd FAQ's

What is Share Price of Jagsonpal Pharmaceuticals Ltd?

What is the Market Cap of Jagsonpal Pharmaceuticals Ltd?

What is PE Ratio of Jagsonpal Pharmaceuticals Ltd?

What is PB Ratio of Jagsonpal Pharmaceuticals Ltd?

What is the CAGR of Jagsonpal Pharmaceuticals Ltd?

How to Buy Jagsonpal Pharmaceuticals Ltd Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Secular & Predictable Business
The company business as a relatively secular business with predictable earnings and cash flows. The predictability of the business will result in lower volatility of price and shareholder returns.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.05. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
Strong Working Capital Cycle
The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.

Valuation Analysis

Margin of safety
(27/03/2025)

102

Margin of Safety Index: High

0% People are bullish about Jagsonpal Pharmaceuticals Ltd

0 % People are bearish about Jagsonpal Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %